Saturday, July 13, 2024

Call for Increased Budget in FP10

Similar articles

In shaping the next European Framework Programme for Research and Innovation (FP10), 110 European associations representing key RD&I stakeholders urge EU Institutions to significantly increase the budget for FP10 and to prioritize pan-European collaborative research to meet industrial needs. As the global technology race accelerates, the EU significantly lags in RD&I investments compared to global competitors, especially in private investments.

This shortfall hampers the EU’s ability to fully capitalize on its scientific and technological potential. To ensure long-term competitiveness, the EU must attract and retain private RD&I investments. The EU Framework Programme plays a vital role in this regard. Public RD&I investments enabled through the EU Framework Programme alleviate market failures and stimulate private RD&I investments by lowering risks for the industry. By pooling resources and expertise, Member States, industry, RTOs, and academia can tackle complex challenges collectively, accelerating technology maturation and innovation.

Proven Impact of EU RD&I Investments

The Ex-post evaluation of Horizon 2020 demonstrated the high financial leverage of EU investments. In institutionalized partnerships, private partners’ contributions more than doubled or tripled the volume of EU investments. The EU Institutions are called upon to significantly increase the current RD&I budget for FP10. Such investments need reinforcement in the next EU budget (MFF). National RD&I investments should meet at least 3% of GDP, leveraging private investments. Committing to technological leadership ensures proper and timely investments.

FP10 must focus on excellent cross-border collaborative RD&I with strong industrial participation. Pillar II, the only truly collaborative part of the FP, must be emphasized, promoting knowledge flow between private and public sectors and between basic and applied research. A significant part of FP10’s budget should be allocated to Pillar II, driven by strategic EU priorities and industrial needs.

Building Long-Term Partnerships

Pillar II is crucial for building trust-based public-private partnerships among European RD&I actors, strengthening Europe’s RD&I ecosystems. This ensures industry uptake of novel technologies, scaling up new solutions, products, and services, improving well-being and quality of life, and increasing European competitiveness. Pillar II, with its industrial partnerships, supports this ambition and needs further strengthening.

Reducing risk and uncertainty and stimulating private investment in Europe requires demonstrating EU support for technology-intensive sectors while preserving technology neutrality. This would incentivize industry to invest in RD&I in Europe, rather than in third countries, and support the delivery of the EU’s green and digital goals. The undersigned associations are ready to discuss FP10’s design with EU Institutions.

Europe has greater potential in the global innovation race than currently realized. To remain a model of economic and social prosperity, Europe must invest strongly in pan-European collaborative RD&I, fostering collaboration, driving technology maturation, and leveraging the expertise of public and private RD&I actors. This investment is crucial for strengthening competitiveness, asserting leadership in key technological domains, and paving the way for a prosperous and sustainable future.

 

You can follow our news on our Telegram and LinkedIn accounts.

Resource: European Federation of Pharmaceutical Industries and Associations, July 04, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article